Cidofovir (compounded solution) |
0.5% |
Ophthalmic |
12 |
Acyclic nucleoside phosphonate, inhibits viral DNA synthesis |
Trifluridine (solution) |
1% |
Ophthalmic |
4–6 |
Fluorinated pyrimidine nucleoside, inhibits viral DNA synthesis |
Ganciclovir (ointment) |
0.15% |
Ophthalmic |
4–6 |
Guanosine analog, inhibits viral DNA synthesis |
Idoxuridine (compounded solution) |
0.1% |
Ophthalmic |
4–6 |
Thymidine analog, inhibits viral DNA synthesis |
Vidarabine (compounded ointment) |
3% |
Ophthalmic |
4–6 |
Adenosine analog, inhibits viral DNA synthesis |
Acyclovir (ointment) |
3% |
Ophthalmic |
4–6 |
Purine analog, inhibits viral DNA synthesis |
Famciclovir (tablet) |
40 mg/kg |
Oral |
8 |
Metabolized to penciclovir, acyclic nucleoside analog, inhibits viral polymerase and DNA synthesis |